Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Neuro Disease Biotech Gains $61M in Early Funds

Brain cell networks

A developer of treatments for Alzheimer’s disease that seeks to improve the condition of the brain’s support cells is raising £48 million ($US 61 million) in its first venture round. . . . → Read More: Neuro Disease Biotech Gains $61M in Early Funds

Infographic – Global Q3 Venture Funding Levels Off

Bar chart: Global venture investment dollars 2021 to 2023

Global venture investment dollars in the third quarter of 2023 rose somewhat from the previous quarter, but remained at about the same level for the past 12 months. . . . → Read More: Infographic – Global Q3 Venture Funding Levels Off

Biomanufacturing Company Gains $9.5M in Early Funds

A company offering a biomanufacturing process it says is more efficient and scalable than conventional bio-production methods is raising $9.5 million in its first venture round. . . . → Read More: Biomanufacturing Company Gains $9.5M in Early Funds

Industry-Academic Center to Boost Rare Disease Therapies

Network pointer

An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K. . . . → Read More: Industry-Academic Center to Boost Rare Disease Therapies

Infographic – Biotech Index Continues Downward Trend

Line chart: Nasdaq Biotechnology Index, Jan - Sept 2023.

The Nasdaq Biotechnology Index, an indicator of investor sentiment in an industry based on science, continued heading down during the third quarter of 2023. . . . → Read More: Infographic – Biotech Index Continues Downward Trend

Cardiac Tech Start-Up Partners with Mayo Clinic

Digital pulse time-series image

A new company developing digital cardiac diagnostics is collaborating with the Mayo Clinic on early detection of coronary artery disease, a key trigger of heart attacks. . . . → Read More: Cardiac Tech Start-Up Partners with Mayo Clinic

Infographic – Q2 Tech Merger Values Up, Deals Down

Bar chart: Tech industry mergers and acquisitions by quarter, 2019 to Q2 2023

The value of mergers and acquisitions in the global technology sector rose for the first time in over a year in the second quarter of 2023, while M&A deal counts dropped somewhat. . . . → Read More: Infographic – Q2 Tech Merger Values Up, Deals Down

University Start-Up Developing Inhaled Gene Therapies

Inspecting lung X-rays

A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies

Autoimmune Neuro Disease Start-Up Raises $58M

Mental health graphic

A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M

Venture Firm, Cancer Center Start Antibody Biotech Company

Antibody illustration

A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company